Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q2 2026 · 10-Q
Revenue$1.77M$1.77M−0.4% vs Q2 2025 Net Income-$14.32M-$14.32MN/M vs Q2 2025 EPS Diluted-$0.17-$0.17N/M vs Q2 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$10,895,000N/M Free Cash Flowderived-$11,225,000N/M Margins · derivedGross margin-43.7%−61.3 pt vs Q2 2025
Operating margin-815.6%−83.4 pt vs Q2 2025
Net margin-808.8%−69.2 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end